Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             126 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acquisition of Inhibitor-Sensitive Protein Kinases through Protein Design Bishop, Anthony C.
1999
2-3 p. 337-346
10 p.
artikel
2 Alteration of drug biotransformation and elimination during infection and inflammation Renton, Kenneth W
2001
2-3 p. 147-163
17 p.
artikel
3 Antisense Oligonucleotide Inhibition of Serine/Threonine Kinases Cho-Chung, Yoon S.
1999
2-3 p. 437-449
13 p.
artikel
4 Apoptosis: the quiet death silences the immune system Sun, E.W.
2001
2-3 p. 135-145
11 p.
artikel
5 Artemisinin and its derivatives: an important new class of antimalarial agents Balint, Gabor A.
2001
2-3 p. 261-265
5 p.
artikel
6 Author Index, Volume 96, 2002 2002
2-3 p. 203-
1 p.
artikel
7 Autonomic control of the venous system in health and disease: effects of drugs Pang, Catherine C.Y
2001
2-3 p. 179-230
52 p.
artikel
8 Basis for effective combination cancer chemotherapy with antimetabolites Peters, G.J.
2000
2-3 p. 227-253
27 p.
artikel
9 Behavioral responses to psychomotor stimulant drugs: Localization in the central nervous system Evenden, J.L.
1988
2-3 p. 151-172
22 p.
artikel
10 Caged Regulators of Signaling Pathways Curley, Kieran
1999
2-3 p. 347-354
8 p.
artikel
11 Catalytic Subunit of Cyclic AMP-Dependent Protein Kinase Taylor, Susan S
1999
2-3 p. 133-141
9 p.
artikel
12 Cell imaging and morphology: application to studies of inherited purine metabolic disorders Connolly, Gerald P.
2001
2-3 p. 267-281
15 p.
artikel
13 Cerebral circulation during diabetes mellitus Mayhan, William G.
1993
2-3 p. 377-391
15 p.
artikel
14 Cerebral vasoconstrictor mediators Toda, Noboru
1993
2-3 p. 359-375
17 p.
artikel
15 Chemical Approaches to the Study of Protein Tyrosine Kinases and Their Implications for Mechanism and Inhibitor Design Cole, Philip A
1999
2-3 p. 219-229
11 p.
artikel
16 Chemical Inhibitors of Cyclin-Dependent Kinases Noble, Martin E.M
1999
2-3 p. 269-278
10 p.
artikel
17 Chloroquine: Mechanism of drug action and resistance in plasmodium falciparum Slater, Andrew F.G.
1993
2-3 p. 203-235
33 p.
artikel
18 CK2 Guerra, B.
1999
2-3 p. 303-313
11 p.
artikel
19 Clinical pharmacology of non-steroidal anti-inflammatory drugs Day, Richard O.
1987
2-3 p. 383-433
51 p.
artikel
20 Conformational Diversity of Catalytic Cores of Protein Kinases Sowadski, Janusz M
1999
2-3 p. 157-164
8 p.
artikel
21 Cyclic ADP-ribose as a second messenger revisited from a new aspect of signal transduction from receptors to ADP-ribosyl cyclase Higashida, Haruhiro
2001
2-3 p. 283-296
14 p.
artikel
22 Cyclic GMP-Dependent Protein Kinases Ruth, Peter
1999
2-3 p. 355-372
18 p.
artikel
23 Cyclic nucleotide analogs as biochemical tools and prospective drugs Schwede, Frank
2000
2-3 p. 199-226
28 p.
artikel
24 Cyclin-Dependent Kinases Sausville, Edward A.
1999
2-3 p. 285-292
8 p.
artikel
25 Cyclin-dependent kinases as potential targets to improve stroke outcome O'Hare, Michael
2002
2-3 p. 135-143
9 p.
artikel
26 Cyclosporin metabolism in transplant patients Christians, U.
1993
2-3 p. 291-345
55 p.
artikel
27 Delineation of Selective Cyclic GMP-Dependent Protein Kinase Iα Substrate and Inhibitor Peptides Based on Combinatorial Peptide Libraries on Paper Dostmann, Wolfgang R.G.
1999
2-3 p. 373-387
15 p.
artikel
28 Delivery systems for antisense oligonucleotides Garcia-Chaumont, Ch
2000
2-3 p. 255-277
23 p.
artikel
29 Dependence as a limiting factor in the clinical use of minor tranquillizers Tyrer, P.
1988
2-3 p. 173-188
16 p.
artikel
30 Designing bisubstrate analog inhibitors for protein kinases Parang, Keykavous
2002
2-3 p. 145-157
13 p.
artikel
31 Designing specific protein kinase inhibitors: Gould, Christine
2002
2-3 p. 169-178
10 p.
artikel
32 Developmental pharmacology and toxicology: Principles of study design and problems of methodology Ward, R.M.
1988
2-3 p. 309-334
26 p.
artikel
33 Diadenosine polyphosphate receptors Pintor, Jesús
2000
2-3 p. 103-115
13 p.
artikel
34 Dietary agents in cancer prevention: flavonoids and isoflavonoids Birt, Diane F.
2001
2-3 p. 157-177
21 p.
artikel
35 Differentiation therapy of human cancer: basic science and clinical applications Leszczyniecka, Magdalena
2001
2-3 p. 105-156
52 p.
artikel
36 Dinucleoside polyphosphates—friend or foe? McLennan, Alexander G
2000
2-3 p. 73-89
17 p.
artikel
37 Docking interactions in the mitogen-activated protein kinase cascades Tanoue, Takuji
2002
2-3 p. 193-202
10 p.
artikel
38 Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs Joyce, Jeffrey N.
2001
2-3 p. 231-259
29 p.
artikel
39 Editorial 1999
2-3 p. 109-110
2 p.
artikel
40 Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors Balzarini, J
2000
2-3 p. 175-187
13 p.
artikel
41 Electrical and structural remodeling of the failing ventricle Armoundas, Antonis A.
2001
2-3 p. 213-230
18 p.
artikel
42 Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias Vos, Marc A.
2001
2-3 p. 109-122
14 p.
artikel
43 Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity Irie, Kazuhiro
2002
2-3 p. 271-281
11 p.
artikel
44 Ethanol and minerals Blachley, Jon D.
1987
2-3 p. 435-448
14 p.
artikel
45 Exploring the mechanisms of vascular smooth muscle tone with highly specific, membrane-permeable inhibitors of cyclic GMP-dependent protein kinase Iα Dostmann, Wolfgang R.G.
2002
2-3 p. 203-215
13 p.
artikel
46 From consensus sequence to high-affinity ligands: acquisition of signaling protein modulators Yeh, Ren-Hwa
2002
2-3 p. 179-191
13 p.
artikel
47 G-protein-coupled receptor dimerization: modulation of receptor function Rios, C.D.
2001
2-3 p. 71-87
17 p.
artikel
48 H-Series Protein Kinase Inhibitors and Potential Clinical Applications Ono-Saito, Nozomi
1999
2-3 p. 123-131
9 p.
artikel
49 Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma Ferrone, S.
1993
2-3 p. 259-290
32 p.
artikel
50 Identification of novel ethanol-sensitive genes by expression profiling Rahman, Sajida
2001
2-3 p. 123-134
12 p.
artikel
51 Index 2000
2-3 p. 287-
1 p.
artikel
52 Index 2000
2-3 p. 285-
1 p.
artikel
53 Index 1999
2-3 p. 451-
1 p.
artikel
54 Index 1999
2-3 p. 453-454
2 p.
artikel
55 Inhibition and activation of c-Src: the head and tail of a coin Fukami, Yasuo
2002
2-3 p. 263-270
8 p.
artikel
56 Inhibition of protein kinase B/Akt Hill, Michelle M.
2002
2-3 p. 243-251
9 p.
artikel
57 Inhibition of Protein Kinase C—Do We, Can We, and Should We? Parker, Peter J
1999
2-3 p. 263-267
5 p.
artikel
58 Inhibition of the Epidermal Growth Factor Receptor Family of Tyrosine Kinases as an Approach to Cancer Chemotherapy Fry, David W.
1999
2-3 p. 207-218
12 p.
artikel
59 Inhibitors of protein glycosylation and glycoprotein processing in viral systems Datema, Roelf
1987
2-3 p. 221-286
66 p.
artikel
60 Inhibitors of Protein Kinases Fabbro, Doriano
1999
2-3 p. 293-301
9 p.
artikel
61 Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties Yoganathan, N.
2002
2-3 p. 233-242
10 p.
artikel
62 Irreversible inhibitors of the erbB family of protein tyrosine kinases Denny, William A.
2002
2-3 p. 253-261
9 p.
artikel
63 Keyword Index, Volume 96, 2002 2002
2-3 p. 205-
1 p.
artikel
64 KID, a Kinase Inhibitor Database Project Collin, Olivier
1999
2-3 p. 165-168
4 p.
artikel
65 Mechanism of Protein Kinase B Activation by Insulin/Insulin-Like Growth Factor-1 Revealed by Specific Inhibitors of Phosphoinositide 3-Kinase—Significance for Diabetes and Cancer Galetic., Ivana
1999
2-3 p. 409-425
17 p.
artikel
66 Metabolic polymorphisms Daly, Ann K.
1993
2-3 p. 129-160
32 p.
artikel
67 Metabolism of natural and synthetic steroids used in cancer treatment Sandberg, A.A.
1988
2-3 p. 263-307
45 p.
artikel
68 Modulation of protein kinase signaling by protein phosphatases and inhibitors Zhang, Zhong-Yin
2002
2-3 p. 307-317
11 p.
artikel
69 Multiplicity of mechanisms of serotonin receptor signal transduction Raymond, John R.
2001
2-3 p. 179-212
34 p.
artikel
70 Neuronal control of airways smooth muscle Pendry, Yvonne D.
1993
2-3 p. 171-202
32 p.
artikel
71 Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications Picciotto, Marina R
2001
2-3 p. 89-108
20 p.
artikel
72 Occurrence and treatment of solvent abuse in children and adolescents Morton, H.G.
1987
2-3 p. 449-469
21 p.
artikel
73 Overview of therapies for prevention of restenosis after coronary interventions Garas, Samer M
2001
2-3 p. 165-178
14 p.
artikel
74 Oxytocin and vasopressin: Photoaffinity labeling of neurophysins, secretory granule hormone-binding proteins Abercrombie, David M.
1987
2-3 p. 209-219
11 p.
artikel
75 P450 enzymes of estrogen metabolism Martucci, Charles P.
1993
2-3 p. 237-257
21 p.
artikel
76 Peptide Inhibitors of the Mitogen-Activated Protein Kinase Pathway Fukami, Yasuo
1999
2-3 p. 399-407
9 p.
artikel
77 PHARMACOLOGY AND THERAPEUTICS An International Review Journal 2002
2-3 p. 325-329
5 p.
artikel
78 PHARMACOLOGY AND THERAPEUTICS AUTHOR INDEX, VOLUME 93, 2002 2002
2-3 p. 319-
1 p.
artikel
79 PHARMACOLOGY AND THERAPEUTICS KEYWORD INDEX, VOLUME 93, 2002 2002
2-3 p. 321-323
3 p.
artikel
80 Pharmacology of Antisense Oligonucleotide Inhibitors of Protein Expression Cooper, Scott R.
1999
2-3 p. 427-435
9 p.
artikel
81 Pharmacology of ethanol Pohorecky, Larissa A.
1988
2-3 p. 335-427
93 p.
artikel
82 PHARMACOLOGY & THERAPEUTICS Name, Name
2001
2-3 p. 297-
1 p.
artikel
83 PHARMACOLOGY & THERAPEUTICS Name, Name
2001
2-3 p. 299-
1 p.
artikel
84 PHARMACOLOGY & THERAPEUTICS An International Review Journal 2001
2-3 p. 235-238
4 p.
artikel
85 PHARMACOLOGY & THERAPEUTICS AUTHOR INDEX, VOLUME 92, 2001 2001
2-3 p. 231-
1 p.
artikel
86 PHARMACOLOGY & THERAPEUTICS KEYWORD INDEX, VOLUME 92, 2001 2001
2-3 p. 233-
1 p.
artikel
87 Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases Van Rompay, An R.
2000
2-3 p. 189-198
10 p.
artikel
88 Photoaffinity labeling of thyroid hormone receptors Horowitz, Zebulun D.
1987
2-3 p. 317-332
16 p.
artikel
89 Photoaffinity labelling of angiotensin receptors: Functional studies on responding tissues Moore, Graham J.
1987
2-3 p. 349-381
33 p.
artikel
90 Photoaffinity labelling of N-formyl peptide receptors Allen, Rodger A.
1987
2-3 p. 333-348
16 p.
artikel
91 Photoaffinity labelling of the adenosine nucleotide transporter of cholinergic vesicles Witzemann, Veit
1987
2-3 p. 287-302
16 p.
artikel
92 p38 Mitogen-Activated Protein Kinase Inhibitors— Mechanisms and Therapeutic Potentials Lee, John C.
1999
2-3 p. 389-397
9 p.
artikel
93 Postmenopausal hot flushes and their management Lomax, Peter
1993
2-3 p. 347-358
12 p.
artikel
94 PREFACE Shugar, David
2002
2-3 p. 77-78
2 p.
artikel
95 Preface Shugar, David
2000
2-3 p. 71-
1 p.
artikel
96 Properties and Potential Applications of Chemical Inhibitors of Cyclin-Dependent Kinases Meijer, Laurent
1999
2-3 p. 279-284
6 p.
artikel
97 Protein kinase inhibitors and antibiotic resistance Burk, David L.
2002
2-3 p. 283-292
10 p.
artikel
98 Protein kinases as targets for anticancer agents: from inhibitors to useful drugs Fabbro, Doriano
2002
2-3 p. 79-98
20 p.
artikel
99 Protein Phosphorylation and Signal Transduction Graves, Jonathan D.
1999
2-3 p. 111-121
11 p.
artikel
100 Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents Levitzki, Alexander
1999
2-3 p. 231-239
9 p.
artikel
101 Selenium effects on drug and foreign compound toxicity Combs Jr, G.F.
1987
2-3 p. 303-315
13 p.
artikel
102 Seventh Symposium of the European Society for the Study of Purine & Pyrimidine Metabolism in Man (ESSPPMM) 2000
2-3 p. 69-
1 p.
artikel
103 Small Molecule Inhibitors of Tumor-Promoted Angiogenesis, Including Protein Tyrosine Kinase Inhibitors Hamby, James M
1999
2-3 p. 169-193
25 p.
artikel
104 Specific and nonspecific enzymes involved in the catabolism of mononucleoside and dinucleoside polyphosphates Guranowski, Andrzej
2000
2-3 p. 117-139
23 p.
artikel
105 Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors Traxler, Peter
1999
2-3 p. 195-206
12 p.
artikel
106 Structural aspects of protein kinase control—role of conformational flexibility Engh, Richard A.
2002
2-3 p. 99-111
13 p.
artikel
107 Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2 Johnson, Louise N.
2002
2-3 p. 113-124
12 p.
artikel
108 Structure, activity, regulation, and inhibitor discovery for a protein kinase associated with apoptosis and neuronal death Velentza, Anastasia V.
2002
2-3 p. 217-224
8 p.
artikel
109 Structure-based design of cyclin-dependent kinase inhibitors Davies, Thomas G.
2002
2-3 p. 125-133
9 p.
artikel
110 Substrate and Inhibitor Recognition of Protein Kinases Graves, Donald
1999
2-3 p. 143-155
13 p.
artikel
111 Synthesis of dinucleoside polyphosphates catalyzed by firefly luciferase and several ligases Sillero, Antonio
2000
2-3 p. 91-102
12 p.
artikel
112 The adenosine-induced mechanism for the acquisition of ischemic tolerance in primary rat neuronal cultures Reshef, Ayelet
2000
2-3 p. 151-159
9 p.
artikel
113 The biochemistry and medical significance of the flavonoids Havsteen, Bent H
2002
2-3 p. 67-202
136 p.
artikel
114 The central neuropharmcology of psychotropic cannabinoids Pertwee, R.G.
1988
2-3 p. 189-261
73 p.
artikel
115 The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy Woodburn, J.R
1999
2-3 p. 241-250
10 p.
artikel
116 The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway Sasaki, Yasuharu
2002
2-3 p. 225-232
8 p.
artikel
117 The role of adenosine in preconditioning de Jong, J.W
2000
2-3 p. 141-149
9 p.
artikel
118 The role of phosphodiesterase inhibitors in heart failure Arnold, J.Malcolm O.
1993
2-3 p. 161-170
10 p.
artikel
119 The Second International Conference on Inhibitors of Protein Kinases (Design–Structural Biology–Phosphorylation/Dephosphorylation Processes–Biochemistry–Biotechnology–Clinical Aspects–Chemotherapy) and Workshop on Computer-Aided Drug Design September 9–15, 2001, Warsaw, Poland 2002
2-3 p. ix-
1 p.
artikel
120 The Transition from a Pharmacophore-Guided Approach to a Receptor-Guided Approach in the Design of Potent Protein Kinase C Ligands Marquez, Victor E
1999
2-3 p. 251-261
11 p.
artikel
121 Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms Sabina, Richard L
2000
2-3 p. 279-283
5 p.
artikel
122 Toward the rational design of protein kinase casein kinase-2 inhibitors Sarno, Stefania
2002
2-3 p. 159-168
10 p.
artikel
123 Tumor-promoting functions of adenosine Spychala, Jozef
2000
2-3 p. 161-173
13 p.
artikel
124 Viral and Host-Cell Protein Kinases Shugar, David
1999
2-3 p. 315-335
21 p.
artikel
125 Virulence- and antibiotic resistance-associated two-component signal transduction systems of Gram-positive pathogenic bacteria as targets for antimicrobial therapy Stephenson, Keith
2002
2-3 p. 293-305
13 p.
artikel
126 Volume 96 Contents 2002
2-3 p. 209-
1 p.
artikel
                             126 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland